drugset / Trial / NCT02904759
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to demonstrate efficacy of desmopressin ODT against placebo for the treatment of male subjects with nocturia due to nocturnal polyuria, during 12 weeks of treatment.
Timeline
- Start
- 2016-09
- Primary completion
- 2017-09-29
- Completion
- 2017-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 25 ug | — |
| Subject | Desmopressin | Peptide | 50 ug | — |